King-Jones Heidy — SEC Form 4 filings

SEC reporting owner CIK 1794898. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-02 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Spyre Therapeutics, Inc. (SYRE)See Remarks45 legs · 28,399 sh · $2,480,5297

Form 4 filings — King-Jones Heidy

FiledFormIssuerReported transactionsSource
2026-09-034Spyre Therapeutics, Inc. (SYRE)Option exercise (M): 27,999 @ $14.50 · Sale (S): 4,845 @ $86.40 · Sale (S): 16,548 @ $87.20 · Sale (S): 6,206 @ $88.17 · Sale (S): 400 @ $89.38 · Option exercise (M): 400 @ $14.50 · +3 moreEDGAR
2026-01-134Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 140,000 (derivative) @ $0EDGAR
2025-01-174Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 95,500 (derivative) @ $0EDGAR
2024-02-024Spyre Therapeutics, Inc. (SYRE)Grant/award (A): 63,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1794898 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →